Early antiretroviral therapy of HIV-infected infants in resource-limited countries: possible, feasible, effective and challenging
- PMID: 18580616
- PMCID: PMC2648848
- DOI: 10.1097/QAD.0b013e32830437f5
Early antiretroviral therapy of HIV-infected infants in resource-limited countries: possible, feasible, effective and challenging
Comment on
-
Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.AIDS. 2008 Jul 11;22(11):1333-43. doi: 10.1097/QAD.0b013e32830437df. AIDS. 2008. PMID: 18580613 Clinical Trial.
References
-
- Chiriboga CA, Fleishman S, Champion S, Gaye-Robinson L, Abrams EJ. Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART) J Pediatr. 2005;146:402–407. - PubMed
-
- Gona P, Van Dyke RB, Williams PL, Dankner WM, Chernoff MC, Nachman SA, Seage GR., 3rd Incidence of opportunistic and other infections in HIV-infected children in the HAART era. Jama. 2006;296:292–300. - PubMed
-
- Judd A, Doerholt K, Tookey PA, Sharland M, Riordan A, Menson E, et al. Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996–2006: planning for teenage and adult care. Clin Infect Dis. 2007;45:918–924. - PubMed
-
- McConnell MS, Byers RH, Frederick T, Peters VB, Dominguez KL, Sukalac T, et al. Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989–2001. J Acquir Immune Defic Syndr. 2005;38:488–494. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical